St. Jude Medical (STJ) Reports In-Line Q2 EPS

Go back to St. Jude Medical (STJ) Reports In-Line Q2 EPS

Abbott (ABT) CEO White says positive reaction to Alere (ALR) release was overdone - Conf. Call

July 20, 2016 9:21 AM EDT

Abbott (NYSE: ABT) CEO Miles D. White says positive reaction to Alere (NYSE: ALR) release was overdone, according to the company's quarterly conference call. White noted that one analyst was "overly enthusiastic" on the Alere update.

... More

Abbott (ABT) Tops Q2 EPS by 2c

July 20, 2016 7:46 AM EDT

Abbott (NYSE: ABT) reported Q2 EPS of $0.55, $0.02 better than the analyst estimate of $0.53. Revenue for the quarter came in at $5.3 billion versus the consensus estimate of $5.24 billion.

International sales increased 2.8 percent on a reported basis and 7.5 percent on an operational basis in the second quarter. International operational growth was led by strong performance across all of Abbott's business segments.

Emerging market sales increased 1.1 percent on a... More